|
業務類別
|
Biotechnology |
|
業務概覽
|
Design Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the research and development of GeneTAC molecules, which are a novel class of small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. Its pipeline includes Friedreich Ataxia, FECD, DM1, and Huntington's Disease. The company operates in one operating and reportable segment focused on utilizing the company's proprietary GeneTAC platform to design and develop therapeutic candidates for inherited diseases driven by nucleotide repeat expansion. |
| 公司地址
| 6005 Hidden Valley Road, Suite 110, Carlsbad, CA, USA, 92011 |
| 電話號碼
| +1 858 293-4900 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.designtx.com |
| 員工數量
| 54 |
| Dr. Pratik Shah, PhD |
Chairperson of the Board, President, Chief Executive Officer and Principal Executive and Financial Officer |
美元 395.00K |
23/04/2026 |
| Ms. Julie Burgess |
Chief Accounting Officer |
-- |
09/03/2026 |
| Mr. Chris Storgard, M.D. |
Chief Medical Officer |
美元 339.31K |
23/04/2026 |
| Dr. Sean Jeffries, PhD |
Chief Operating Officer |
美元 484.00K |
23/04/2026 |
|
|
| Mr. David Shapiro, M.D. |
Director |
01/04/2026 |
| Dr. Pratik Shah, PhD |
Chairperson of the Board, President, Chief Executive Officer and Principal Executive and Financial Officer |
23/04/2026 |
| Dr. David Shapiro, M.D. |
Independent Director |
23/04/2026 |
| Dr. Heather Berger, PhD |
Independent Director |
23/04/2026 |
| Mr. John P. Schmid |
Independent Director |
23/04/2026 |
| Mr. Justin David Gover |
Independent Director |
23/04/2026 |
| Dr. Rodney W. Lappe, PhD |
Independent Director |
23/04/2026 |
| Dr. Simeon J. George, M.B.A.,M.D. |
Lead Independent Director |
23/04/2026 |
|
|
|
|
